Your session is about to expire
← Back to Search
Group 1 for Pain
Study Summary
This trial tests the safety and effects of a drug on heart rhythm, how the body processes it, and how it affects the body.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
Is the enrollment of individuals over 55 years old permissible in this trial?
"The age range for this research is 18-55 years old."
Has Group 1 gained regulatory approval from the U.S. Food and Drug Administration?
"Since this is a Phase 1 trial, with limited data concerning its safety and efficacy, we at Power rate Group 1's security as a score of 1."
Am I qualified to access the benefits of this experiment?
"Qualifying individuals must demonstrate symptoms of pain and be between the ages 18 and 55 in order to join this medical research. The trial is looking for approximately 72 participants."
Is the recruitment process of this trial still underway?
"According to information presented on clinicaltrials.gov, recruitment for this medical study is ongoing and the trial was originally posted on April 12th 2023 with a recent update being made May 5th 2023."
How many participants are being administered the treatment in this research endeavor?
"Yes, the information hosted on clinicaltrials.gov verifies that this research venture is actively seeking out participants. This trial was originally posted April 12th 2023 and has been revised as recently as May 5th 2023. 72 individuals are being sought from 2 distinct sites for enrollment in this study."
Share this study with friends
Copy Link
Messenger